СУБЕТТА(Subetta)

Nazione: Uzbekistan

Lingua: russo

Fonte: Oʻzbekiston Respublikasi Sogʻliqni saqlash vazirligi (Министерство здравоохранения Республики Узбекистан)

Principio attivo:

Comb.drug (Affinity purified antibodies to endothelial NO synthase & Affinity purified antibodies to the C-terminal fragment of insulin receptor beta subunit)

Commercializzato da:

Материа Медика Холдинг, НПФ, ООО

Codice ATC:

A10BX

INN (Nome Internazionale):

Comb.drug (Affinity purified antibodies to endothelial NO synthase & Affinity purified antibodies to the C-terminal fragment of insulin receptor beta subunit)

Forma farmaceutica:

Таблетки для рассасывания гомеопатические N20 (1х20), N40 (2x20), N100 (5x20) (упаковки контурные ячейковые)

Area terapeutica:

Противодиабетическое средство

Dettagli prodotto:

Код ФТГ: по рецепту

Data dell'autorizzazione:

2020-09-18

Prodotti simili

Principio attivo Comb.drug (Affinity purified antibodies to endothelial NO synthase & Affinity purified antibodies to the C-terminal fragment of insulin receptor beta subunit)

Comb.drug (Affinity purified antibodies to endothelial NO synthase & Affinity purified antibodies to the C-terminal fragment of insulin receptor beta subunit)

Codice ATC A10BX

A10BX

Commercializzato da Материа Медика Холдинг, НПФ, ООО

Материа Медика Холдинг, НПФ, ООО

INN (Nome Internazionale) Comb.drug (Affinity purified antibodies to endothelial NO synthase & Affinity purified antibodies to the C-terminal fragment of insulin receptor beta subunit)

Comb.drug (Affinity purified antibodies to endothelial NO synthase & Affinity purified antibodies to the C-terminal fragment of insulin receptor beta subunit)

Cerca alert relativi a questo prodotto

Avvisi СУБЕТТА Comb.drug

СУБЕТТА Comb.drug

Visualizza cronologia documenti

Cronologia dei documenti Cronologia dei documenti

СУБЕТТА(Subetta)